Apoptosis inhibitor of macrophage/CD5L is associated with disease activity in rheumatoid arthritis.
CONCLUSIONS: AIM may serve as a novel sensitive biomarker to assist disease activity assessment and monitor therapeutic effects in active RA patients.
PMID: 32194022 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research
More News: Arthritis | Laboratory Medicine | Osteoarthritis | Rheumatoid Arthritis | Rheumatology | Study